James H. Reamer

Array ( [id] => 4346416 [patent_doc_number] => 06284763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Methods for remodeling neuronal and cardiovascular pathways' [patent_app_type] => 1 [patent_app_number] => 9/382749 [patent_app_country] => US [patent_app_date] => 1999-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8046 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284763.pdf [firstpage_image] =>[orig_patent_app_number] => 382749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353935 [patent_doc_number] => 06254881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Antiinfective free intramammary veterinary composition' [patent_app_type] => 1 [patent_app_number] => 9/319544 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2445 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/254/06254881.pdf [firstpage_image] =>[orig_patent_app_number] => 319544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4419313 [patent_doc_number] => 06194467 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Diabetes remedies' [patent_app_type] => 1 [patent_app_number] => 9/367163 [patent_app_country] => US [patent_app_date] => 1999-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6632 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194467.pdf [firstpage_image] =>[orig_patent_app_number] => 367163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4205550 [patent_doc_number] => RE037003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Pharmaceutical composition for inhibiting the growth of cancers' [patent_app_type] => 2 [patent_app_number] => 9/368685 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1813 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037003.pdf [firstpage_image] =>[orig_patent_app_number] => 368685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101345 [patent_doc_number] => 06049001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Fluorine-containing carboxylic acid compounds, methods for their production, and chemical processes utilizing the same' [patent_app_type] => 1 [patent_app_number] => 9/362090 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3002 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/049/06049001.pdf [firstpage_image] =>[orig_patent_app_number] => 362090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239847 [patent_doc_number] => 06080748 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Therapeutic use of JAK-3 inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/361491 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 15 [patent_no_of_words] => 20606 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080748.pdf [firstpage_image] =>[orig_patent_app_number] => 361491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249778 [patent_doc_number] => 06221910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Glutamine containing oral replacement solution' [patent_app_type] => 1 [patent_app_number] => 9/358462 [patent_app_country] => US [patent_app_date] => 1999-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1234 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221910.pdf [firstpage_image] =>[orig_patent_app_number] => 358462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305072 [patent_doc_number] => 06251940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Inflammatory cell inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/355002 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10110 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 688 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251940.pdf [firstpage_image] =>[orig_patent_app_number] => 355002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261617 [patent_doc_number] => 06258850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => '3-aryl-2-hydroxypropionic acid derivative (I)' [patent_app_type] => 1 [patent_app_number] => 9/341904 [patent_app_country] => US [patent_app_date] => 1999-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9743 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258850.pdf [firstpage_image] =>[orig_patent_app_number] => 341904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478717 [patent_doc_number] => 06451815 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Method of enhancing bioavailability of fexofenadine and its derivatives' [patent_app_type] => B1 [patent_app_number] => 09/353462 [patent_app_country] => US [patent_app_date] => 1999-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6321 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451815.pdf [firstpage_image] =>[orig_patent_app_number] => 09353462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143847 [patent_doc_number] => 06030998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Methods for treating arrhythmia using acetate buffer solutions of amiodarone' [patent_app_type] => 1 [patent_app_number] => 9/350846 [patent_app_country] => US [patent_app_date] => 1999-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3388 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030998.pdf [firstpage_image] =>[orig_patent_app_number] => 350846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086210 [patent_doc_number] => 06162835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Stable active-ingredient combination for the disinfection and cleaning of contact lenses, and packing and process for the preparation thereof' [patent_app_type] => 1 [patent_app_number] => 9/349581 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1584 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162835.pdf [firstpage_image] =>[orig_patent_app_number] => 349581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260859 [patent_doc_number] => 06258797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Combating infection in delivery systems' [patent_app_type] => 1 [patent_app_number] => 9/331366 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2686 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258797.pdf [firstpage_image] =>[orig_patent_app_number] => 331366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359320 [patent_doc_number] => 06174914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Method of inhibiting cytokine release from human ocular cells' [patent_app_type] => 1 [patent_app_number] => 9/333454 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2207 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174914.pdf [firstpage_image] =>[orig_patent_app_number] => 333454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550125 [patent_doc_number] => 06346537 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Medicinal composition' [patent_app_type] => B1 [patent_app_number] => 09/308672 [patent_app_country] => US [patent_app_date] => 1999-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7262 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 547 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346537.pdf [firstpage_image] =>[orig_patent_app_number] => 09308672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548664 [patent_doc_number] => 06399093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Method and composition to treat musculoskeletal disorders' [patent_app_type] => B1 [patent_app_number] => 09/314829 [patent_app_country] => US [patent_app_date] => 1999-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6566 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399093.pdf [firstpage_image] =>[orig_patent_app_number] => 09314829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171810 [patent_doc_number] => 06140363 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of SH2-mediated processes' [patent_app_type] => 1 [patent_app_number] => 9/312405 [patent_app_country] => US [patent_app_date] => 1999-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10158 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140363.pdf [firstpage_image] =>[orig_patent_app_number] => 312405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237689 [patent_doc_number] => 06143756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Antimalarial activity of .beta.-carboline alkaloids' [patent_app_type] => 1 [patent_app_number] => 9/310826 [patent_app_country] => US [patent_app_date] => 1999-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3148 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143756.pdf [firstpage_image] =>[orig_patent_app_number] => 310826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134327 [patent_doc_number] => 06121302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Stabilization of isothiazolone' [patent_app_type] => 1 [patent_app_number] => 9/309686 [patent_app_country] => US [patent_app_date] => 1999-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121302.pdf [firstpage_image] =>[orig_patent_app_number] => 309686 [rel_patent_id] =>[rel_patent_doc_number] =>)